Home > News > ACLARA Receives 4 U.S. Patents
April 5th, 2004
ACLARA Receives 4 U.S. Patents
ACLARA BioSciences announced the issuance of four U.S. patents that strengthen the intellectual property around its eTag technology: Nos. 6,682,887 and No. 6,686,152 with claims related to certain eTag applications; No. 6,673,550 with broad claims related to certain specific eTag reporter molecules including assays related to protein and protein complex expression; and No. 6,685,813 with claims related to eTag sample handling in a nanofluidic setting.
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014
First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014
Ki-Bum Lee Patents Technology To Advance Stem Cell Therapeutics November 13th, 2014
'Direct writing' of diamond patterns from graphite a potential technological leap November 5th, 2014